Company: GMRE
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001104659-25-110926
Chunk: 68

Company: Global Medical REIT Inc.
Filing Date: 2025-11-13
Form: 424B5
Chunk 68
---
 of any holder of Series A Preferred Stock.

In addition, the affirmative vote or written consent
of the holders of at least two-thirds of the outstanding shares of Series A Preferred Stock and each other class or series of parity preferred
stock with like voting rights (voting together as a single class) is required for us to amend, alter or repeal any provision of our charter,
whether by merger, consolidation or otherwise, so as to materially and adversely affect the voting rights, powers or preferences of the
Series A Preferred Stock, unless the Series A Preferred Stock remains outstanding without the terms thereof being materially adversely
changed in any way adverse to the holders thereof or is converted into or exchanged for preferred stock of the surviving entity having
preferences, conversion and other rights, voting powers, restrictions, limitations as to dividends, qualifications and terms and conditions
of redemption thereof that are substantially similar to those of the Series A Preferred Stock. If such amendment to our charter disproportionately
affects the terms of the Series A Preferred Stock relative to the terms of one or more other classes or series of parity preferred stock,
the affirmative vote or written consent of the holders of at least two-thirds of the outstanding shares of Series A Preferred Stock (voting
separately as a class) is required.

| 12 |

In any matter in which holders of Series A Preferred
Stock may vote (as expressly provided in the terms of the Series A Preferred Stock), each holder of Series A Preferred Stock shall be
entitled to one vote per share.

Information Rights. During any period in
which we are not subject to Section 13 or 15(d) of the Exchange Act and any shares of Series A Preferred Stock are outstanding, we will
(i) post to our website or transmit by mail (or other permissible means under the Exchange Act) to all holders of Series A Preferred Stock,
as their names and addresses appear on our record books and without cost to such holders, copies of the Annual Reports on Form 10-K and
Quarterly Reports on Form 10-Q, respectively, that we would have been required to file with the SEC pursuant to Section 13 or 15(d) of
the Exchange Act if we were subject thereto (other than any exhibits that would have been required) and (ii) promptly, upon request, supply
copies of such reports to any holders or prospective holder of Series A Preferred Stock. We will post to our website or mail (or otherwise
provide) the information to the holders of the Series A Preferred Stock within